SCVC led the pre-seed round with backing from Deep Science Ventures and Cambridge Enterprise VC to help the startup expand its team and partnerships.
HB
Houdini Bio
Houdini Bio develops software that redesigns therapeutic DNA so the body does not attack it.
Cambridge, UK—Founded 2025
£1.5MTotal raised
Cambridge-based biotechnology startup developing software that redesigns therapeutic DNA to prevent cellular silencing. The firm uses machine learning to improve gene therapy durability and performance.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Houdini Bio's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders

Lee Dunham
Chief Business Officer
Lee co-founded Houdini Bio as Chief Business Officer, following business development roles at the Cell and Gene Therapy Catapult.
LinkedInInvestors
Funding history
£1.5M
-20webclip.png)

